S&P Global Boosts FY24 Outlook - Update

RTTNews | 377 दिनों पहले
S&P Global Boosts FY24 Outlook - Update

(RTTNews) - While reporting financial results for the first quarter on Thursday, data giant S&P Global, Inc. (SPGI) raised its earnings, adjusted earnings and revenue growth guidance for the full-year 2024.

For fiscal 2024, the company now projects earnings in a range of $10.80 to $11.05 per share and adjusted earnings in a range of $13.85 to $14.10 per share on revenue growth of 6 to 8 percent.

Previously, the company expected earnings in a range of $10.70 to $10.95 per share and adjusted earnings in a range of $13.75 to $14.00 per share on revenue growth of 5.5 to 7.5 percent.

On average, 21 analysts polled by Thomson Reuters expect the company to report earnings of $14.11 per share on revenue growth of 7.5 percent to $13.43 billion for the year. Analysts' estimates typically exclude special items.

For the full year 2024, the Company expects to return approximately 85% of adjusted free cash flow to shareholders through dividends and share repurchases.

The Board of Directors has also authorized a quarterly cash dividend of $0.91. The Company expects to execute additional share repurchases totaling approximately $1.3 billion through the third quarter of 2024.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

टैग: SPGI
read more
SEC Fines Moody's, S&P, Other Credit Rating Agencies Over Recordkeeping Failures

SEC Fines Moody's, S&P, Other Credit Rating Agencies Over Recordkeeping Failures

The U.S. Securities and Exchange Commission has fined six major credit rating organizations a total of $49 million for significant failures to maintain and preserve electronic communications. Admitting the facts in their respective SEC orders, Moody's Investor Service Inc. and S&P Global Ratings agreed to pay a $20 million civil penalty each. Further, Fitch Ratings Inc. agreed to pay $8 million...
RTTNews | 245 दिनों पहले
S&P Global Reiterates FY23 Outlook - Update

S&P Global Reiterates FY23 Outlook - Update

While reporting financial results for the second quarter on Thursday, data giant S&P Global, Inc. (SPGI) reiterated its earnings, adjusted pro forma earnings and adjusted pro forma revenue growth guidance for the full-year 2023.
RTTNews | 650 दिनों पहले
FTSE Modestly Lower In Cautious Trade

FTSE Modestly Lower In Cautious Trade

The U.K. market is modestly lower on Wednesday as investors largely tread cautiously, digesting earnings and regional economic data, and awaiting the monetary policy announcements from the Federal Reserve and the Bank of England.
RTTNews | 1घंटे 14 मिनट पहले
UK Construction Sector Continues To Shrink

UK Construction Sector Continues To Shrink

The UK construction activity continued to contract in April as business uncertainty and concerns about economic outlook damped client demand, survey data from S&P Global showed on Wednesday. The construction Purchasing Managers' Index rose unexpectedly to 46.6 in April from 46.4 in March. This was the slowest decline in output levels for three months.
RTTNews | 1घंटे 18 मिनट पहले
CAC 40 Moderately Lower Ahead Of Fed Policy Announcement

CAC 40 Moderately Lower Ahead Of Fed Policy Announcement

French stocks are down in negative territory Wednesday morning with investors making cautious moves, reacting to earnings, and awaiting the Federal Reserve's monetary policy announcement, due later in the day.
RTTNews | 1घंटे 42 मिनट पहले
Euro Rises Against Majors

Euro Rises Against Majors

The euro strengthened against other major currencies in the European session on Wednesday.
RTTNews | 2घंटे 12 मिनट पहले
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook

Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook

Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews | 2घंटे 21 मिनट पहले